BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/4/2018 12:36:47 PM | Browse: 1168 | Download: 1169
 |
Received |
|
2017-11-12 06:01 |
|
Peer-Review Started |
|
2017-11-12 10:02 |
|
To Make the First Decision |
|
2017-12-01 07:24 |
|
Return for Revision |
|
2017-12-04 03:54 |
|
Revised |
|
2017-12-22 20:19 |
|
Second Decision |
|
2018-01-16 06:42 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2018-01-24 00:57 |
|
Articles in Press |
|
2018-01-24 00:57 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2018-02-23 18:36 |
|
Publish the Manuscript Online |
|
2018-03-04 12:36 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Glycogenic hepatopathy: A narrative review
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Jagannath M Sherigar, Joline De Castro, Yong Mei Yin, Debra Guss and Smruti R Mohanty |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Smruti R Mohanty, FACP, MD, Chief Doctor, Department of Gastroenterology and Hepatology, NYP-Brooklyn Methodist Hospital, 5841 S. Maryland Avenue, 506, 6th Street, Brooklyn, NY 11215, United States. srm9006@nyp.org |
| Key Words |
Glycogenic hepatopathy; Diabetes mellitus; Hepatomegaly; Mauriac syndrome; Elevated liver enzymes; Liver biopsy; Gradient dual-echo MRI |
| Core Tip |
Glycogenic hepatopathy (GH) is considered as a benign reversible condition. Elevation in transaminases is a common finding in patients with diabetes mellitus, non-alcoholic fatty liver disease (NAFLD) and GH are the two primary underlying pathologies in most cases. It is essential to distinguish NAFLD from glycogenic hepatopathy as this can progress to advanced liver disease. However, recent studies have identified the varying degree of fibrosis in glycogen hepatopathy as well, further emphasizing the need for future studies. We briefly reviewed the literature on mechanisms involved in the development of GH, evaluation of these patients, recent progress made on diagnostic tests and management. |
| Publish Date |
2018-03-04 12:36 |
| Citation |
Sherigar JM, Castro JD, Yin YM, Guss D, Mohanty SR. Glycogenic hepatopathy: A narrative review. World J Hepatol 2018; 10(2): 172-185 |
| URL |
http://www.wjgnet.com/1948-5182/full/v10/i2/172.htm |
| DOI |
http://dx.doi.org/10.4254/wjh.v10.i2.172 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
